Neopharmed Gentili S.p.A. agreed to acquire Biocryst Ireland Limited from BioCryst Pharmaceuticals, Inc. for approximately $260 million.

Published: 2025-06-27 14:05:39 ET BCRX

Published on 06/27/2025 at 14:05